Search
Search Results
-
Enoxaparin for VTE thromboprophylaxis during inpatient rehabilitation care: assessment of the standard fixed dosing regimen
BackgroundWe aimed to examine the efficiency of fixed daily dose enoxaparin (40 mg) thromboprophylaxis strategy for patients undergoing inpatient...
-
Awareness and associated factors of venous thromboembolism in breast cancer surgical patients: a cross-sectional study
BackgroundVenous thromboembolism (VTE) is a major complication of breast cancer surgical patients. Assessing VTE awareness enables medical staff to...
-
Acute venous thromboembolism plasma and red blood cell metabolomic profiling reveals potential new early diagnostic biomarkers: observational clinical study
BackgroundVenous thromboembolism (VTE) is a leading cause of cardiovascular mortality. The diagnosis of acute VTE is based on complex imaging exams...
-
Risk of venous thromboembolism in patients undergoing gastric cancer surgery: a systematic review and meta-analysis
BackgroundVenous thromboembolism (VTE) is a common postoperative complication in patients undergoing surgery for gastric cancer (GC). Although VTE...
-
Genetic correlations, shared risk genes and immunity landscapes between COVID-19 and venous thromboembolism: evidence from GWAS and bulk transcriptome data
BackgroundPatients with coronavirus disease 2019 (COVID-19) were vulnerable to venous thromboembolism (VTE), which further increases the risk of...
-
Venous Thromboembolism: Review of Clinical Challenges, Biology, Assessment, Treatment, and Modeling
Venous thromboembolism (VTE) is a massive clinical challenge, annually affecting millions of patients globally. VTE is a particularly consequential...
-
Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database
BackgroundVenous thromboembolism (VTE) and cancer are strongly associated. In France, evidence on patients with pancreatic, upper GI...
-
Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development
Genome-wide association studies (GWAS) have identified numerous risk loci for venous thromboembolism (VTE), but it is challenging to decipher the...
-
Thrombogenetic Risk at High Altitude: Early Diagnosis and Treatment Modalities
Venous thrombosis (VT) is a complex preventable medical condition. Its manifestation depends on several acquired and inherited genetic risk factors....
-
Laboratory Evaluation of Thrombophilia
Venous thromboembolism (VTE) occurs typically in the veins of the lower extremities and/or as pulmonary embolism. There is a myriad of causes of VTE...
-
Protocols for D-Dimer Measurements for Aid to Diagnosis or Exclusion of Venous Thromboembolism
Measuring D-dimer is commonly used as a surrogate to indicate a clot-forming process, with subsequent lysis. This test has two primary intended uses:...
-
Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin – propensity score matching study
BackgroundVenous thromboembolic disease (VTE) is characterized by obstruction of venous blood flow by a thrombus. Survival data, frequency of disease...
-
Nomogram prediction for the risk of venous thromboembolism in patients with lung cancer
ObjectiveThe aim of this study was to establish a nomogram graph model to accurately predict the venous thromboembolism (VTE) risk probability in the...
-
Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolism
We report a genome-wide association study of venous thromboembolism (VTE) incorporating 81,190 cases and 1,419,671 controls sampled from six cohorts....
-
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study
PurposeJAK-inhibitors (JAK-i) might be associated with venous (VTE) and arterial thromboembolic events (ATE). To evaluate the association between...
-
Efficacy of the bleeding risk scoring system for optimal prophylactic anticoagulation therapy of venous thromboembolism in trauma patients: a single-center, retrospective, observational cohort study
BackgroundWe developed a bleeding risk scoring system (BRSS) using prophylactic anticoagulation therapy to comprehensively assess the risk of venous...
-
Thrombotic Complications in Women: Risks and Prevention
Two main clinical manifestations of venous thrombo-embolism (VTE) include deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT refers to a...
-
High Altitude Induced Thrombosis: Challenges and Recent Advancements in Pathogenesis and Management
Venous thrombosis and pulmonary embolism together form a serious disorder of accelerated and unwanted intravascular blood clot formation which is...
-
Evaluation of Activated Protein C Resistance Using Thrombin Generation Test
Activated protein C (APC) resistance (APCR) has been identified as a risk factor of venous thromboembolism (VTE). A mutation at the level of factor...
-
Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors
The regimens for factor Xa (FXa) inhibitors (apixaban, edoxaban, and rivaroxaban) vary with venous thromboembolism (VTE) or non-valvular atrial...
